Triangle Securities Wealth Management Biogen Inc. Transaction History

Triangle Securities Wealth Management

$349 Million
Q2 2024

A detailed history of Triangle Securities Wealth Management transactions in Biogen Inc. stock. As of the latest transaction made, Triangle Securities Wealth Management holds 2,400 shares of BIIB stock, worth $417,096. This represents 0.16% of its overall portfolio holdings.

Number of Shares

2,400

Previous 2,400 -0.0%

Holding current value

$417,096

Previous $517,000 7.54%

% of portfolio

0.16%

Previous 0.15%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 10, 2023	SELL	$253.3 - $285.89 $25,330 - $28,589	-100 Reduced 4.0%	2,400 $616,000
Q1 2023 Apr 20, 2023	SELL	$256.56 - $292.34 $20,781 - $23,679	-81 Reduced 3.14%	2,500 $695,000
Q4 2022 Jan 11, 2023	SELL	$252.44 - $306.72 $93,907 - $114,099	-372 Reduced 12.6%	2,581 $0
Q3 2022 Oct 19, 2022	SELL	$194.69 - $268.46 $15,185 - $20,939	-78 Reduced 2.57%	2,953 $788,000
Q2 2022 Jul 11, 2022	SELL	$187.54 - $223.02 $29,818 - $35,460	-159 Reduced 4.98%	3,031 $618,000
Q1 2022 Apr 13, 2022	SELL	$193.77 - $244.14 $11,044 - $13,915	-57 Reduced 1.76%	3,190 $672,000
Q4 2021 Jan 14, 2022	SELL	$223.92 - $287.77 $44,784 - $57,554	-200 Reduced 5.8%	3,247 $779,000
Q3 2021 Oct 14, 2021	SELL	$282.99 - $369.05 $10,753 - $14,023	-38 Reduced 1.09%	3,447 $975,000
Q2 2021 Jul 12, 2021	SELL	$259.0 - $414.71 $129,241 - $206,940	-499 Reduced 12.53%	3,485 $1.21 Million
Q1 2021 Apr 12, 2021	SELL	$242.95 - $284.63 $40,572 - $47,533	-167 Reduced 4.02%	3,984 $1.12 Million
Q4 2020 Jan 11, 2021	SELL	$236.26 - $355.63 $80,800 - $121,625	-342 Reduced 7.61%	4,151 $1.02 Million
Q3 2020 Oct 09, 2020	SELL	$264.77 - $305.71 $29,124 - $33,628	-110 Reduced 2.39%	4,493 $1.28 Million
Q2 2020 Jul 08, 2020	SELL	$258.66 - $342.55 $125,708 - $166,479	-486 Reduced 9.55%	4,603 $1.23 Million
Q1 2020 Apr 06, 2020	SELL	$268.85 - $341.04 $158,083 - $200,531	-588 Reduced 10.36%	5,089 $1.61 Million
Q4 2019 Jan 09, 2020	SELL	$220.06 - $304.07 $139,518 - $192,780	-634 Reduced 10.05%	5,677 $1.69 Million
Q3 2019 Oct 15, 2019	SELL	$217.44 - $243.88 $82,627 - $92,674	-380 Reduced 5.68%	6,311 $1.47 Million
Q2 2019 Jul 10, 2019	SELL	$219.29 - $241.72 $26,753 - $29,489	-122 Reduced 1.79%	6,691 $1.55 Million
Q1 2019 Apr 08, 2019	BUY	$216.71 - $338.96 $13,002 - $20,337	60 Added 0.89%	6,813 $1.61 Million
Q4 2018 Jan 17, 2019	BUY	$278.5 - $352.75 $27,850 - $35,275	100 Added 1.5%	6,753 $2.03 Million
Q3 2018 Oct 04, 2018	SELL	$293.51 - $383.83 $52,831 - $69,089	-180 Reduced 2.63%	6,653 $2.35 Million
Q2 2018 Jul 12, 2018	SELL	$257.52 - $306.91 $18,026 - $21,483	-70 Reduced 1.01%	6,833 $1.98 Million
Q1 2018 Apr 11, 2018	BUY	$260.13 - $367.91 $81,160 - $114,787	312 Added 4.73%	6,903 $1.89 Million
Q4 2017 Jan 10, 2018	SELL	$307.64 - $344.58 $51,068 - $57,200	-166 Reduced 2.46%	6,591 $2.1 Million
Q3 2017 Oct 11, 2017	BUY	$281.15 - $329.69 $1.9 Million - $2.23 Million	6,757	6,757 $2.12 Million

Others Institutions Holding BIIB

# of Institutions

1,018

Shares Held

128M

Call Options Held

1.22M

Put Options Held

1.4M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Triangle Securities Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Triangle Securities Wealth Management with notifications on news.

Account

Triangle Securities Wealth Management Biogen Inc. Transaction History